Health Effects of the Standardized Research E-Cigarette in Smokers With HIV Smokers With HIV

Recruiting N/A Interventional Study
HIV
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Interventional
Purpose
Other
Participants needed
72 (estimated)
Sponsor
Brown University · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Cigarette smoking is more prevalent (50-70%) in persons living with HIV in the U.S. when compared with the general population and is linked to increased rates of heart disease, lung diseases and infections, and lung cancers. Because of their high levels of nicotine dependence, low quit rates, and familiarity with harm reduction, HIV-positive smokers may view the use of alternative nicotine deliver…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * diagnosed with and engaged in care for HIV (defined as at least one HIV clinic medical appointment within the past six month period) * at least 18 years of age * smoke at least 5 cigarettes per day for longer than one year * exhaled carbon monoxide (CO) level greater than 5 at…
Contacts

PATRICIA A CIOE, PhD

401-863-6638

patricia_cioe@brown.edu

CONTACT

Jasmine DiLorenzo, BA

401-863-6645

jasminette_dilorenzo@brown.edu

CONTACT